BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Braoudaki M, Lambrou GI, Giannikou K, Milionis V, Stefanaki K, Birks DK, Prodromou N, Kolialexi A, Kattamis A, Spiliopoulou CA, Tzortzatou-Stathopoulou F, Kanavakis E. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms. J Hematol Oncol 2014;7:96. [PMID: 25551588 DOI: 10.1186/s13045-014-0096-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Chadda KR, Blakey EE, Coleman N, Murray MJ. The clinical utility of dysregulated microRNA expression in paediatric solid tumours. European Journal of Cancer 2022;176:133-154. [DOI: 10.1016/j.ejca.2022.09.010] [Reference Citation Analysis]
2 Hill RM, Plasschaert SLA, Timmermann B, Dufour C, Aquilina K, Avula S, Donovan L, Lequin M, Pietsch T, Thomale U, Tippelt S, Wesseling P, Rutkowski S, Clifford SC, Pfister SM, Bailey S, Fleischhack G. Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment. Cancers (Basel) 2021;14:126. [PMID: 35008290 DOI: 10.3390/cancers14010126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lambrou GI, Poulou M, Giannikou K, Themistocleous M, Zaravinos A, Braoudaki M. Differential and Common Signatures of miRNA Expression and Methylation in Childhood Central Nervous System Malignancies: An Experimental and Computational Approach. Cancers (Basel) 2021;13:5491. [PMID: 34771655 DOI: 10.3390/cancers13215491] [Reference Citation Analysis]
4 Lambrou GI, Zaravinos A, Braoudaki M. Co-Deregulated miRNA Signatures in Childhood Central Nervous System Tumors: In Search for Common Tumor miRNA-Related Mechanics. Cancers (Basel) 2021;13:3028. [PMID: 34204289 DOI: 10.3390/cancers13123028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Tang K, Gardner S, Snuderl M. The Role of Liquid Biopsies in Pediatric Brain Tumors. J Neuropathol Exp Neurol 2020;79:934-40. [PMID: 32766689 DOI: 10.1093/jnen/nlaa068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
6 Madlener S, Gojo J. Liquid Biomarkers for Pediatric Brain Tumors: Biological Features, Advantages and Perspectives. J Pers Med 2020;10:E254. [PMID: 33260839 DOI: 10.3390/jpm10040254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
7 Fei L, Sun G, You Q. miR-642a-5p partially mediates the effects of lipopolysaccharide on human pulmonary microvascular endothelial cells via eEF2. FEBS Open Bio 2020;10:2294-304. [PMID: 32881411 DOI: 10.1002/2211-5463.12969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Yi W, Liu J, Qu S, Fan H, Lv Z. An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer. Technol Cancer Res Treat 2020;19:1533033820965594. [PMID: 33054579 DOI: 10.1177/1533033820965594] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Bogner EM, Daly AF, Gulde S, Karhu A, Irmler M, Beckers J, Mohr H, Beckers A, Pellegata NS. miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance. Int J Cancer 2020;147:3523-38. [PMID: 32856736 DOI: 10.1002/ijc.33268] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
10 Laneve P, Caffarelli E. The Non-coding Side of Medulloblastoma. Front Cell Dev Biol 2020;8:275. [PMID: 32528946 DOI: 10.3389/fcell.2020.00275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Li C, Zou H, Xiong Z, Xiong Y, Miyagishima DF, Wanggou S, Li X. Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma. Front Genet 2020;11:429. [PMID: 32508873 DOI: 10.3389/fgene.2020.00429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 The Non-Coding RNA Repressor GAS5 of the Glucocorticoid Receptor: Insights to Its Role in Human Malignancies. Med One 2020. [DOI: 10.20900/mo20200003] [Reference Citation Analysis]
13 Chen Y, Zhao J, Duan Z, Gong T, Chen W, Wang S, Xu H. miR‑27b‑3p and miR‑607 cooperatively regulate BLM gene expression by directly targeting the 3'‑UTR in PC3 cells. Mol Med Rep 2019;19:4819-31. [PMID: 30957187 DOI: 10.3892/mmr.2019.10135] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Khan IN, Ullah N, Hussein D, Saini KS. Current and emerging biomarkers in tumors of the central nervous system: Possible diagnostic, prognostic and therapeutic applications. Seminars in Cancer Biology 2018;52:85-102. [DOI: 10.1016/j.semcancer.2017.07.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
15 Ahram M, Amarin JZ, Suradi HH, Abdelhamid SS, Makhamreh MM, Bawadi RM, Al-hussaini M. Association of MicroRNAs with the Clinicopathologic Characteristics of Ependymoma. J Mol Neurosci 2018;66:307-13. [DOI: 10.1007/s12031-018-1178-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
16 Li H, Chen L, Li JJ, Zhou Q, Huang A, Liu WW, Wang K, Gao L, Qi ST, Lu YT. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. J Hematol Oncol 2018;11:70. [PMID: 29843746 DOI: 10.1186/s13045-018-0618-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 82] [Article Influence: 18.0] [Reference Citation Analysis]
17 Tantawy M, Elzayat MG, Yehia D, Taha H. Identification of microRNA signature in different pediatric brain tumors. Genet Mol Biol 2018;41:27-34. [PMID: 29658967 DOI: 10.1590/1678-4685-GMB-2016-0334] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
18 Ma C, Zhang W, Wu Q, Liu Y, Wang C, Lao G, Yang L, Liu P. Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma. PLoS One 2018;13:e0193625. [PMID: 29513728 DOI: 10.1371/journal.pone.0193625] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
19 Gershanov S, Toledano H, Michowiz S, Barinfeld O, Pinhasov A, Goldenberg-Cohen N, Salmon-Divon M. MicroRNA-mRNA expression profiles associated with medulloblastoma subgroup 4. Cancer Manag Res 2018;10:339-52. [PMID: 29497332 DOI: 10.2147/CMAR.S156709] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
20 Kim HK, Tyryshkin K, Elmi N, Feilotter H, Andreazza AC. Examining redox modulation pathways in the post-mortem frontal cortex in patients with bipolar disorder through data mining of microRNA expression datasets. J Psychiatr Res 2018;99:39-49. [PMID: 29407286 DOI: 10.1016/j.jpsychires.2018.01.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
21 Lykoudi A, Kolialexi A, Lambrou GI, Braoudaki M, Siristatidis C, Papaioanou GK, Tzetis M, Mavrou A, Papantoniou N. Dysregulated placental microRNAs in Early and Late onset Preeclampsia. Placenta 2018;61:24-32. [PMID: 29277268 DOI: 10.1016/j.placenta.2017.11.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
22 Wei CH, Wu G, Cai Q, Gao XC, Tong F, Zhou R, Zhang RG, Dong JH, Hu Y, Dong XR. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway. J Hematol Oncol 2017;10:125. [PMID: 28629431 DOI: 10.1186/s13045-017-0493-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 10.6] [Reference Citation Analysis]
23 Papadavid E, Braoudaki M, Bourdakou M, Lykoudi A, Nikolaou V, Tounta G, Ekonomidi A, Athanasiadis E, Spyrou G, Antoniou C, Kitsiou-tzeli S, Rigopoulos D, Kolialexi A. Aberrant microRNA expression in tumor mycosis fungoides. Tumor Biol 2016;37:14667-75. [DOI: 10.1007/s13277-016-5325-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
24 Braoudaki M, Lambrou GI, Giannikou K, Papadodima SA, Lykoudi A, Stefanaki K, Sfakianos G, Kolialexi A, Tzortzatou-Stathopoulou F, Tzetis M, Kitsiou-Tzeli S, Kanavakis E. miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas. Tumour Biol 2016;37:9887-97. [PMID: 26813564 DOI: 10.1007/s13277-016-4903-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
25 Braoudaki M, Lambrou GI, Papadodima SA, Stefanaki K, Prodromou N, Kanavakis E. MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors. Med Oncol 2016;33. [DOI: 10.1007/s12032-015-0719-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
26 Lou G, Song X, Yang F, Wu S, Wang J, Chen Z, Liu Y. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015;8:122. [PMID: 26514126 DOI: 10.1186/s13045-015-0220-7] [Cited by in Crossref: 387] [Cited by in F6Publishing: 416] [Article Influence: 55.3] [Reference Citation Analysis]